JP2023517919A5 - - Google Patents
Info
- Publication number
- JP2023517919A5 JP2023517919A5 JP2022554381A JP2022554381A JP2023517919A5 JP 2023517919 A5 JP2023517919 A5 JP 2023517919A5 JP 2022554381 A JP2022554381 A JP 2022554381A JP 2022554381 A JP2022554381 A JP 2022554381A JP 2023517919 A5 JP2023517919 A5 JP 2023517919A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- approximately
- pharmaceutically acceptable
- acceptable salt
- combination according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062987963P | 2020-03-11 | 2020-03-11 | |
| US62/987,963 | 2020-03-11 | ||
| PCT/EP2021/056210 WO2021180857A1 (en) | 2020-03-11 | 2021-03-11 | Combinations of beta-lactam compounds, probenecid, and valproic acid and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023517919A JP2023517919A (ja) | 2023-04-27 |
| JP2023517919A5 true JP2023517919A5 (https=) | 2024-03-21 |
| JP7797401B2 JP7797401B2 (ja) | 2026-01-13 |
Family
ID=74871410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022554381A Active JP7797401B2 (ja) | 2020-03-11 | 2021-03-11 | β－ラクタム化合物、プロベネシド、及びバルプロ酸の組み合わせとその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12128034B2 (https=) |
| EP (1) | EP4117645A1 (https=) |
| JP (1) | JP7797401B2 (https=) |
| KR (1) | KR20220152261A (https=) |
| CN (1) | CN115190797B (https=) |
| AU (1) | AU2021235058A1 (https=) |
| BR (1) | BR112022015925A2 (https=) |
| CA (1) | CA3169900A1 (https=) |
| MX (1) | MX2022011238A (https=) |
| WO (1) | WO2021180857A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11554112B2 (en) | 2018-06-07 | 2023-01-17 | Herum Therapeutics International Limited | Combinations of β-lactam compounds and probenecid and uses thereof |
| EP3790535A1 (en) | 2019-02-13 | 2021-03-17 | Iterum Therapeutics International Limited | Combinations of beta-lactam compounds and probenecid and uses thereof |
| CN116650490B (zh) * | 2023-06-07 | 2025-05-20 | 中国人民解放军海军军医大学 | 化合物mt-1207在降低尿酸方面的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| EP2278999B1 (en) | 2008-04-21 | 2025-01-29 | Dompé farmaceutici S.p.A. | Auris formulations for treating otic diseases and conditions |
| CN101897687B (zh) * | 2009-05-26 | 2012-07-04 | 中国科学院上海生命科学研究院 | 丙戊酸钠治疗肝脏炎症相关疾病的新用途 |
| EP3427729A1 (en) | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid for use in treating epileptic diseases, disorders or conditions |
| US11554112B2 (en) * | 2018-06-07 | 2023-01-17 | Herum Therapeutics International Limited | Combinations of β-lactam compounds and probenecid and uses thereof |
| EP3790535A1 (en) * | 2019-02-13 | 2021-03-17 | Iterum Therapeutics International Limited | Combinations of beta-lactam compounds and probenecid and uses thereof |
-
2021
- 2021-03-11 CA CA3169900A patent/CA3169900A1/en active Pending
- 2021-03-11 US US17/198,335 patent/US12128034B2/en active Active
- 2021-03-11 MX MX2022011238A patent/MX2022011238A/es unknown
- 2021-03-11 WO PCT/EP2021/056210 patent/WO2021180857A1/en not_active Ceased
- 2021-03-11 KR KR1020227034566A patent/KR20220152261A/ko active Pending
- 2021-03-11 AU AU2021235058A patent/AU2021235058A1/en active Pending
- 2021-03-11 BR BR112022015925A patent/BR112022015925A2/pt unknown
- 2021-03-11 JP JP2022554381A patent/JP7797401B2/ja active Active
- 2021-03-11 CN CN202180020106.6A patent/CN115190797B/zh active Active
- 2021-03-11 EP EP21711548.4A patent/EP4117645A1/en active Pending
-
2024
- 2024-09-26 US US18/897,353 patent/US20250120953A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6883688B2 (ja) | バイオアベイラビリティが高いアルボシジブプロドラッグ | |
| JP2023517919A5 (https=) | ||
| JP2022121594A5 (https=) | ||
| JP2022545005A5 (https=) | ||
| JP2025069304A5 (https=) | ||
| JP2022191257A5 (https=) | ||
| JP2016534063A5 (https=) | ||
| JPWO2023027198A5 (https=) | ||
| JP2013519632A5 (https=) | ||
| JP2021525787A5 (https=) | ||
| JP2023553534A5 (https=) | ||
| JP2021530554A5 (https=) | ||
| JP2021519764A5 (https=) | ||
| JP2004502732A5 (https=) | ||
| JP2020510085A5 (https=) | ||
| JP2023011769A5 (https=) | ||
| JP2018531273A5 (https=) | ||
| JP2023553533A5 (https=) | ||
| ES2312978T3 (es) | Potenciador del efecto antitumoral y agente antitumoral. | |
| KR20180059390A (ko) | 근육통과 관련된 상태의 치료를 위한 배합물 | |
| JP4511183B2 (ja) | 神経変性疾患および心臓血管疾患の治療 | |
| JP2019531286A5 (https=) | ||
| JP2004506619A (ja) | 性的機能障害用医薬 | |
| JP2015510517A5 (https=) | ||
| JP2022518288A5 (https=) |